Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group
  2. Taxonomy
  3. Term
  4. Other

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy.

Go back to Resources

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.

Go back to Resources

Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.

Authors:

Secondary:

Volume:

Pagination:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.

Go back to Resources

Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Chimpanzee Adenovirus Vector Ebola Vaccine.

Go back to Resources

Chimpanzee Adenovirus Vector Ebola Vaccine.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.

Go back to Resources

Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative.

Go back to Resources

Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Rigid-compulsive behaviors are associated with mixed bowel symptoms in autism spectrum disorder.

Go back to Resources

Rigid-compulsive behaviors are associated with mixed bowel symptoms in autism spectrum disorder.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.

Go back to Resources

Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Impact of patient use of an online patient portal on diabetes outcomes.

Go back to Resources

Impact of patient use of an online patient portal on diabetes outcomes.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Central site monitoring: results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection.

Go back to Resources

Central site monitoring: results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • Previous page ‹‹
  • Page 71
  • Next page ››
Subscribe to Other
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification